The mRNA-based COVID-19 vaccines do not harm in vitro fertilization (IVF) success rates, according to a recent study, countering disinformation that vaccines could negatively affect fertility. In contrast, the SARS-CoV2 virus has been found to negatively affect the quality of embryos for couples who are undergoing IVF treatments and sperm. The peer-reviewed study, published in […] Continue reading ->
Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions.  Meanwhile high-income countries have dropped […] Continue reading ->
Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading ->
Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE).   So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading ->
The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday.  The  announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading ->
Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics.  The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs).  In comparison […] Continue reading ->
Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are  struggling roll out efficiently.  Reflections on the first anniversary of the massive COVAX vaccine rollout.  On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading ->